These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 17701864

  • 1. [Use of infliximab in ulcerative colitis].
    Tilg H, Feichtenschlager T, Knoflach P, Petritsch W, Schöfl R, Vogelsang H, Reinisch W.
    Z Gastroenterol; 2007 Aug; 45(8):907-11. PubMed ID: 17701864
    [Abstract] [Full Text] [Related]

  • 2. A review of infliximab use in ulcerative colitis.
    Wilhelm SM, McKenney KA, Rivait KN, Kale-Pradhan PB.
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis.
    Su C, Salzberg BA, Lewis JD, Deren JJ, Kornbluth A, Katzka DA, Stein RB, Adler DR, Lichtenstein GR.
    Am J Gastroenterol; 2002 Oct; 97(10):2577-84. PubMed ID: 12385442
    [Abstract] [Full Text] [Related]

  • 4. Infliximab for the treatment of ulcerative colitis.
    Eshuis EJ, Bemelman WA, Stokkers PC.
    Expert Rev Gastroenterol Hepatol; 2009 Jun; 3(3):219-29. PubMed ID: 19485804
    [Abstract] [Full Text] [Related]

  • 5. Infliximab in the treatment of severe ulcerative colitis: a follow-up study.
    Kohn A, Prantera C, Pera A, Cosintino R, Sostegni R, Daperno M.
    Eur Rev Med Pharmacol Sci; 2004 Jun; 8(5):235-7. PubMed ID: 15638237
    [Abstract] [Full Text] [Related]

  • 6. Infliximab in ulcerative colitis.
    Aberra FN, Lichtenstein GR.
    Gastroenterol Clin North Am; 2006 Dec; 35(4):821-36. PubMed ID: 17129815
    [Abstract] [Full Text] [Related]

  • 7. Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus.
    Herrlinger KR, Barthel DN, Schmidt KJ, Büning J, Barthel CS, Wehkamp J, Stange EF, Fellermann K.
    Aliment Pharmacol Ther; 2010 May; 31(9):1036-41. PubMed ID: 20175769
    [Abstract] [Full Text] [Related]

  • 8. Experience of maintenance infliximab therapy for refractory ulcerative colitis from six centres in England.
    Russo EA, Harris AW, Campbell S, Lindsay J, Hart A, Arebi N, Milestone A, Tsai HH, Walters J, Carpani M, Westaby D, Thillainayagam A, Bansi D, Ghosh S.
    Aliment Pharmacol Ther; 2009 Feb 01; 29(3):308-14. PubMed ID: 19035973
    [Abstract] [Full Text] [Related]

  • 9. Infliximab in the treatment of steroid-dependent ulcerative colitis.
    Armuzzi A, De Pascalis B, Lupascu A, Fedeli P, Leo D, Mentella MC, Vincenti F, Melina D, Gasbarrini G, Pola P, Gasbarrini A.
    Eur Rev Med Pharmacol Sci; 2004 Feb 01; 8(5):231-3. PubMed ID: 15638236
    [Abstract] [Full Text] [Related]

  • 10. [Infliximab in moderate to severe steroid-dependent or steroid-refractory ulcerative colitis].
    Mocciaro F, Orlando A, Scimeca D, Cottone M.
    Recenti Prog Med; 2007 Nov 01; 98(11):560-4. PubMed ID: 18044405
    [Abstract] [Full Text] [Related]

  • 11. [Aminosalicylates and steroids in the treatment ot chronic inflammatory bowel diseases--consensus paper of the Working Group for Chronic Inflammatory Bowel Diseases of the OGGH].
    Dejaco C, Haas T, Kirchgatterer A, Miehsler W, Wenzl H, Knoflach P, Petritsch W, Vogelsang H, Reinisch W, Tilg H.
    Z Gastroenterol; 2006 Jun 01; 44(6):525-38; discussion 539. PubMed ID: 16773519
    [Abstract] [Full Text] [Related]

  • 12. Review article: Infliximab therapy for inflammatory bowel disease--seven years on.
    Rutgeerts P, Van Assche G, Vermeire S.
    Aliment Pharmacol Ther; 2006 Feb 15; 23(4):451-63. PubMed ID: 16441465
    [Abstract] [Full Text] [Related]

  • 13. [Infliximab therapy for Crohn's disease - a practical guideline: actualised consensus of the working group for chronic inflammatory bowel diseases of the Austrian Society for Gastroenterology and Hepatology].
    Reinisch W, Dejaco C, Feichtenschlager T, Haas T, Kaser A, Miehsler W, Novacek G, Petritsch W, Platzer R, Tilg H, Vogelsang H, Knoflach P, Arbeitsgruppe Chronisch-entzündliche Darmerkrankungen der ÖGGH.
    Z Gastroenterol; 2011 Apr 15; 49(4):534-42. PubMed ID: 21442574
    [Abstract] [Full Text] [Related]

  • 14. Infliximab for the treatment of acute exacerbations of ulcerative colitis.
    Bryan S, Andronis L, Hyde C, Connock M, Fry-Smith A, Wang D.
    Health Technol Assess; 2010 May 15; 14 Suppl 1():9-15. PubMed ID: 20507798
    [Abstract] [Full Text] [Related]

  • 15. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
    Aratari A, Papi C, Clemente V, Moretti A, Luchetti R, Koch M, Capurso L, Caprilli R.
    Dig Liver Dis; 2008 Oct 15; 40(10):821-6. PubMed ID: 18472316
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of servere ulcerative colitis].
    Weersma RK, van Dullemen HM, Kleibeuker JH, Ploeg RJ, Dijkstra G.
    Ned Tijdschr Geneeskd; 2006 Jan 07; 150(1):12-7. PubMed ID: 16440618
    [Abstract] [Full Text] [Related]

  • 17. Infliximab for refractory ulcerative colitis.
    Chey WY, Hussain A, Ryan C, Potter GD, Shah A.
    Am J Gastroenterol; 2001 Aug 07; 96(8):2373-81. PubMed ID: 11513177
    [Abstract] [Full Text] [Related]

  • 18. Anti-tumour necrosis factor therapy for ulcerative colitis: evidence to date.
    Thukral C, Cheifetz A, Peppercorn MA.
    Drugs; 2006 Aug 07; 66(16):2059-65. PubMed ID: 17112300
    [Abstract] [Full Text] [Related]

  • 19. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
    Yamamoto-Furusho JK, Uzcanga LF.
    Dig Surg; 2008 Aug 07; 25(5):383-6. PubMed ID: 19005257
    [Abstract] [Full Text] [Related]

  • 20. The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients.
    Feagan BG, Reinisch W, Rutgeerts P, Sandborn WJ, Yan S, Eisenberg D, Bala M, Johanns J, Olson A, Hanauer SB.
    Am J Gastroenterol; 2007 Apr 07; 102(4):794-802. PubMed ID: 17324131
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.